Outro Health

Outro Health

Referral automation platform for B2B

Overview

Outro Health offers a B2B SaaS platform that automates referral generation and management for sales, recruiting, and networking. It helps organizations tap their existing networks by guiding introductions through a Triple Opt-in workflow where a user requests a match, a Connector approves it, and the Prospect agrees to be connected. Its Outro Pro plan provides unlimited licenses, CRM integration, team management, and a built-in rewards system to support ongoing referrals and relationship-building. The company differentiates itself by systematizing referrals into a scalable, auditable process that works across lead generation, recruiting, and investor outreach with CRM compatibility, with the goal of generating qualified introductions to accelerate business development, hiring, and investor relations.

About Outro Health

Simplify's Rating
Why Outro Health is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

Enterprise Software

Company Size

11-50

Company Stage

Seed

Total Funding

$1.4M

Headquarters

Taylorsville, Utah

Founded

2014

Get referred to Outro Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 site updates show operations across 14 states, expanding market access.
  • Outro is preparing benzodiazepine and gabapentinoid programs, broadening beyond antidepressants.
  • Axios reported a planned large seed raise in 2025 after a $2.2 million pre-seed.

What critics are saying

  • Insurance in-network expansion remains unfinished, constraining patient acquisition and revenue.
  • Compounded low-dose prescriptions depend on pharmacy partners, creating operational and regulatory fragility.
  • Regulators or psychiatrists rejecting hyperbolic tapering would crush demand and undermine Outro's core product.

What makes Outro Health unique

  • Mark Horowitz's hyperbolic tapering protocol anchors Outro's clinical positioning.
  • Outro operates medically supervised deprescribing, not generic telehealth medication management.
  • Custom doses mailed home reduce tablet-splitting friction for low-dose antidepressant tapering.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1.4M

Below

Industry Average

Funded Over

2 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$1.5M
Slack
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood

Benefits

Health Insurance

Paid Vacation

Paid Holidays

Remote Work Options

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Business Wire
Nov 1st, 2022
Antidepressant Tapering Platform Outro Launches In Canada Ahead Of World Tapering Day

TORONTO--(BUSINESS WIRE)--Outro, the first-of-its-kind platform harnessing technology and specialized care to help people reduce or stop the use of antidepressants, announces its launch in Canada ahead of World Tapering Day on November 5. Outro’s user-friendly platform provides science-based, personalized tapering plans to slowly reduce medication dosage. It also provides proactive symptom monitoring, one-on-one chats and video appointments with practitioners trained specifically in safely stopping antidepressants, and a patient-first approach that minimizes risk of relapse and maximizes the chance of successful tapering. Outro is slated for a United States launch in 2023

Recently Posted Jobs

Sign up to get curated job recommendations

Outro Health is Hiring for 5 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →